Recombinant saccharomyces cerevisiae engineering bacterium with high yield of nepetalactone as well as optimization method and application thereof
Through systematic engineering strategies and metabolic process optimization, a high-yield Nepalactone Saccharomyces cerevisiae strain was constructed, which solved the problem of excessively low biosynthesis of Nepalactone, achieved efficient synthesis and stable yield, and met the needs of industrial production.
Patent Information
- Application Number
- CN202411203273.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-11-22
AI Technical Summary
In the prior art, the biosynthesis yield of necrolactone is too low, and it is difficult to replace traditional processes for large-scale production. Especially in Saccharomyces cerevisiae, the yield of necrolactone synthesis is only 3.10 mg/L/OD600, and heterologous. The problems of gene adaptation and catalyzed specific allocation of ISY enzymes in the host seriously restrict the flux of nematodeol and nematodeol.
Through system engineering strategies (enzyme fusion expression, regulation of endogenous cofactor balance) and metabolic process optimization (chromosome integration, two-phase fermentation, and nutritional defect labeling completion), Saccharomyces cerevisiae strains with high yields, including crHGO, including crHGO) are constructed by system engineering strategies (enzyme fusion expression, regulation of endogenous cofactor balance) and optimization of metabolic process (chromosome integration, two-phase fermentation, and nutritional defect labeling). , a combination expression cassette and plasmid of nmISY, NEPS1, MLPL and ZWF1 genes optimized the heterologous synthesis pathway of neoligolactone and solved the problem of cofactor imbalance.
The efficient synthesis of neoligolactone was achieved, and the output was significantly increased to 2478.89 mg/L. The stability and output met the requirements of industrial production, providing favorable evidence for the subsequent optimization of the production of isodarin and vinblastine.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present invention relates to the field of bioengineering, and in particular to a high-yield nepetalactone recombinant brewer's yeast engineering bacterium and an optimization method and application thereof. Background Art
[0002] Nepetalactone is a bicyclic monoterpenoid, whose molecule contains two fused rings, namely cyclopentane and a six-membered lactone. Nepetalactone is mainly the active chemical contained in catnip (Nepeta cataria) and is volatile. As the main component of catnip that causes excitement in cats, nepetalactone binds to protein receptors on the epidermal cells of the cat's nasal cavity, transmits and stimulates the cat's brain, causing the cat to produce various reactions such as rolling, scratching and purring. Nepetalactone has insect repellent, hypnotic and antibacterial effects. In the medical field, it can be used to produce sleeping pills, antispasmodics, antipyretics, etc. In addition, nepetalactone is also widely used in insect repellent, which can be used to repel cockroaches, mosquitoes, flies, etc. Nepetalactone can be added to hydrogen to produce dihydronepetalactone, which is a highly effective insect repellent compound, and its mosquito repellent ability is several times that of the mainstream ingredient DEET.
[0003] Natural nepetalactone is mainly extracted from catnip, while chemically synthesized nepetalactone is synthesized using limonene, nepetalic acid or citronellal as starting materials. The production efficiency is low, the cost is high, and the insufficient output makes it impossible to achieve large-scale application. In order to solve the related problems, the process of microbial synthesis of nepetalactone is receiving widespread attention in the market. In recent years, people have conducted in-depth analysis of the biosynthetic pathway of nepetalactone. Figure 1 As shown in the figure, the biosynthetic pathway of nepetalactone is to use glucose as a substrate and generate geraniol via the MVA pathway. Geraniol is catalyzed by the P450 enzyme G8H to generate 8-hydroxygeraniol, which is then oxidized in two steps by the HGO enzyme to generate 8-oxogeranal, which is reduced by the ISY enzyme to generate an enol intermediate, which is cyclized spontaneously or via the MLPL enzyme to generate nepetalol. Nepetalol is finally catalyzed by the NEPS1 enzyme to generate nepetalactone.
[0004] In 2019, researchers used a yeast-based whole-cell biocatalytic method to produce nepetalactone from 8-hydroxygeraniol through a four-step enzymatic process. After single-factor optimization, factor design and response surface methodology were used for multi-factor optimization, which increased the yield of nepetalactone by 5.8 times to 153 mg / L.
[0005] In 2021, the researchers conducted a multi-step, one-pot in vitro reaction using geraniol as a substrate. ISY was added after the G8H and GOR reactions were completed, and the nine enzymes in the pathway were incubated with geraniol to produce 930 mg / L nepetalactone in 8.5 hours (geraniol needed to be fed every 1.5 hours).
[0006] In 2021, researchers first achieved the synthesis of nepetalactone in Saccharomyces cerevisiae, with a yield of only 3.10 mg / L / OD 600 (OD 600 This is the only successful case of de novo biosynthesis of nepetalactone. However, due to its low yield, it is difficult to replace traditional processes for large-scale production.
[0007] In 2024, researchers achieved the synthesis of nepetalol (precursor of nepetalactone) in Pichia pastoris. By constructing a yeast factory with dual peroxisomes and cytoplasm, and then mating the two yeasts, diploid yeast was generated, with a 24-well plate yield of 1172.6 mg / L and a 5L fermentation tank yield of 4429.4 mg / L.
[0008] So far, the difficulty of synthesizing nepetalactone in a heterologous host lies in the adaptation problems between genes in the pathway, between pathway genes and chassis, and the catalytic specificity distribution of ISY enzymes. ISY enzymes can reduce 8-oxogeranal to enol intermediates and geraniol to byproduct citronellol, which seriously restricts the flux of nepetalol, nepetalactone and even downstream pathways. The in vitro synthesis of nepetalactone focuses on avoiding the formation of by-products by adding intermediates or adding ISY enzymes in steps. However, since in vitro reactions require complex systems and reaction procedures, they are not conducive to industrial production. De novo biosynthesis of nepetalactone has gradually come into the sight of researchers, but due to the low yield (3.10 mg / L / OD 600 , O.D. 600 About 5-6), it is difficult to replace the traditional method for production. Summary of the invention
[0009] In view of this, the present invention provides a high-yield nepetalactone recombinant brewer's yeast engineering bacteria and its optimization method and application. The present invention achieves efficient synthesis of nepetalactone by means of system engineering strategy (enzyme fusion expression, regulation of endogenous cofactor balance) and metabolic process optimization (chromosome integration, two-phase fermentation, nutritional deficiency label completion), thereby obtaining a stable and high-yield nepetalactone brewer's yeast strain. The present invention determines the necessity of precursor substrates to the entire heterologous pathway, and that the heterologous synthesis pathway of nepetalactone produces a cofactor imbalance disturbance on endogenous metabolism, providing favorable evidence for the subsequent optimization and production of isothiocyanate and vinblastine.
[0010] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0011] The present invention provides a gene combination, including: crHGO gene, nmISY gene and NEPS1 gene.
[0012] In some embodiments of the present invention, the above gene combination further includes: MLPL gene and / or ZWF1 gene.
[0013]
[0014]
[0015] In some embodiments of the present invention, for the above gene combination, the above NEPS1 gene sequence is as shown in SEQ ID NO:3: ATGGCATCCACCGCTAACCCAATGCAAGTTATGAAAAAGAAATTGGAAGGTAAGGTTGTTATTGTTACCGGTGGTGCTTCCGGTATTGGTCAAACTGCTGCTAGAGTTTTTGCTCAACATGGTGCTAGAGCTGTTGTTATTGCTGATATTCAATCCGAAGTTGGTAAGTCTGTTGCTAAAAGTATTGGTGATCCTTGTTGTTATGTTCAATGTGATGTTTCTGATGAAGAAGAAGTTAAATCTATGATTGAATGGACTGCTTCTGCTTATGGTGGTTTGGATATGATGTTTTCTAATGTTGGTATTATGTCCAAGTCTGCTCAAACTGTTATGGATTTGGATTTGTTGGAATTTGATAAGGTTATGAGAGTTAACGCTAGAGGTATGGCTGCTTGTTTGAAACATGCTGCTAGAAAGATGGTTGAATTGGGTACTAGAGGTACTATTATTTGTACTACTACTCCTTTGTCTTCTAGAGGTGGTCAATCTATGACTGATTATGCTATGTCTAAGCATGCAGTTATGGGTTTGGTTAGATCTGCTTCTATTCAATTAGGTGCTCATGGTATTAGAGTTAACTGTGTTACTCCTTCAGTTGTTTTGACTCCATTGGCTCAAAGAATGGGTTTGGCTACTCCAGATGATTTTCATACACATTTTGGTAACTTCACTAGTTTGAAAGGTGTTTATTTGACTCCTGAACAAGTTGCTGAAGCTGTTGTTTATTTGGCTTCTGATGATGCTGCTTTTATTACTGGTCATGATTTGGTTTTGGATGGTGGTTTGTTGTGTTTGCCTTTTTTTGCTCCTTCTTAA。
[0016] In some embodiments of the present invention, for the above gene combination, the above MLPL gene sequence is as shown in SEQ ID NO:4: ATGGCATCCAAATTGGAAATTGAAATTGAATTGAAGTCCGATGTTGAAAAGATGTGGAAGCATTTCAAGGAATTTACCAAGTTGTTCCCAAAGGCTTGTCCACATTTGTATGAAAAGATTGATGTTATTCAAGGTGATGGTATTTCCGTTGGTACTATTTTCGTTTCCACCTTGAAGCCAACTGAATTGAATCCAGTTGTTATGGTTACCAAGGAAAAGATTGATTTCTTGGATGATGATAACAAGATGTTGAGATACTCCTACATGGAAGGTGAAATTTTGAAGAACTACAAGAACTTGAGAGGTATTGTTCATATGTCCTCCTCAAAGAACGGTGGTACTATTTTCAAGTACTCCGGTGAATTTGAAAAGGCTAACGAACAAGTTCCAGATCCTGTTTTCTTCAAGGATTTCATGGTTATTGTTTTCCAAAGATTGGATGATTACGTTTTGAACGGTATGAACCATACCTGTCAAAACTAA。
[0017]
[0018] The present invention also provides an expression cassette, comprising: the above gene combination.
[0019] The present invention also provides an enzyme combination, comprising: an ISY enzyme, an HGO enzyme, a NEPS1 enzyme and an MLPL enzyme.
[0020] In some embodiments of the present invention, the above-mentioned expression cassette includes: one or more of expression cassette 1 to expression cassette 4;
[0021] The expression cassette 1 comprises: the crHGO gene and / or the nmISY gene;
[0022] The expression cassette 2 includes: the NEPS1 gene;
[0023] The expression cassette 3 includes: the MLPL gene;
[0024] The expression cassette 4 includes: the ZWF1 gene.
[0025] In some embodiments of the present invention, the above expression cassette further comprises: one or more of a promoter, a terminator and a tag.
[0026] In some embodiments of the present invention, the promoter in the above expression cassette includes: GAL7 and / or GAL1,10;
[0027] The terminator includes: GPD1 ;
[0028] The tag includes: URA3 gene and / or LEU gene.
[0029] The present invention also provides a plasmid, comprising: the above expression cassette.
[0030] The present invention also provides a recombinant strain for transforming, transfecting and / or integrating the above plasmid and / or expression cassette.
[0031] In some embodiments of the present invention, in the above-mentioned recombinant strain, the transformed and / or transfected chassis strain includes: one or more of yeast, mold, bacteria and algae.
[0032] In some embodiments of the present invention, in the above-mentioned recombinant strain, the yeast comprises: one or more of Saccharomyces cerevisiae, Saccharomyces lipolytica and Kluyveromyces.
[0033] In some embodiments of the present invention, in the above-mentioned recombinant strains, the Saccharomyces cerevisiae includes: CEN.PK series and / or BY series.
[0034] In some embodiments of the present invention, in the above-mentioned recombinant strains, the CEN.PK series includes: CEN.PK2-1c.
[0035] In some embodiments of the present invention, in the above-mentioned recombinant strain, the mold includes: Streptomyces.
[0036] In some embodiments of the present invention, in the above-mentioned recombinant strain, the bacteria include: Escherichia coli and / or Bacillus subtilis.
[0037] The present invention also provides the use of the above gene combination, the above expression cassette, the above plasmid and / or the above recombinant strain in the production and / or preparation of nepetalactone.
[0038] The present invention also provides a method for preparing nepetalactone, which comprises inoculating the above recombinant strain, fermenting and culturing the strain, and obtaining the nepetalactone.
[0039] In some embodiments of the present invention, in the above method, the fermentation culture includes the step of adding an organic phase; the organic phase includes: isopropyl myristate.
[0040] In some embodiments of the present invention, in the above method, the amount of isopropyl myristate added is 20% v / v.
[0041] The present invention provides a gene combination, including: crHGO gene, nmISY gene and NEPS1 gene.
[0042] The present invention achieves efficient synthesis of nepetalactone by utilizing system engineering strategies (enzyme fusion expression, regulation of endogenous cofactor balance) and metabolic process optimization (chromosome integration, two-phase fermentation, nutritional deficiency label completion), thereby obtaining a stable and high-yield nepetalactone yeast strain. The present invention determines the necessity of precursor substrates for the entire heterologous pathway, and that the heterologous synthesis pathway of nepetalactone produces cofactor imbalance disturbances in endogenous metabolism, providing favorable evidence for the subsequent optimization of the production of isothiocyanate and vinblastine. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below.
[0044] Figure 1 The biosynthetic pathway of nepetalactone is shown;
[0045] Figure 2 Shows the temperament detection diagram of nepetalactone;
[0046] Figure 3 It shows that the fusion of HGO and ISY can improve the production of nepetalactone;
[0047] Figure 4 The effect of introducing MLPL gene on the yield of nepetalactone in production strains is shown;
[0048] Figure 5 The effect of adding IPM to two-phase fermentation on the yield of nepetalactone in the production strain is shown;
[0049] Figure 6 The effect of cofactor regulation on the yield of nepetalactone in the production strain is shown;
[0050] Figure 7 The results show the effect of chromosome integration on the production of nepetalactone in the production strain;
[0051] Figure 8 The results show the effect of complementing the nutritional deficiency tag on the production of nepetalactone in the production strain. DETAILED DESCRIPTION
[0052] The invention discloses a high-yield nepetalactone recombinant brewer's yeast engineering bacterium and an optimization method and application thereof.
[0053] It should be understood that the expression "one or more of..." includes each of the items recited after the expression individually and in various different combinations of two or more of the recited items, unless otherwise understood from the context and usage. The expression "and / or" in combination with three or more recited items should be understood to have the same meaning, unless otherwise understood from the context.
[0054] The use of the terms "comprising", "having" or "containing", including their grammatical synonyms, should generally be understood as open and non-restrictive, for example not excluding other unrecited elements or steps, unless otherwise specifically stated or otherwise understood from the context.
[0055] It should be understood that the order of steps or the order in which certain actions are performed is not important as long as the present invention remains operable. In addition, two or more steps or actions may be performed simultaneously.
[0056] The use of any and all examples or exemplary language, such as "for example" or "including", herein is intended only to better illustrate the invention and does not limit the scope of the invention unless otherwise claimed. No language in this specification should be construed as indicating that any non-claimed element is essential to the practice of the invention.
[0057] In addition, the numerical ranges and parameters used to define the present invention are approximate values, and the relevant values in the specific embodiments have been presented as accurately as possible. However, any numerical value inherently inevitably contains standard deviations due to individual test methods. Therefore, unless otherwise expressly stated, it should be understood that all ranges, quantities, values and percentages used in this disclosure are modified by "about". Here, "about" generally means that the actual value is within plus or minus 10%, 5%, 1% or 0.5% of a specific value or range.
[0058] In Examples 1 to 8 of the present invention, all the raw materials and reagents used can be purchased from the market.
[0059] The present invention will be further described below in conjunction with embodiments:
[0060] Example 1 Construction of nepetalactone biosynthetic pathway
[0061] The method for constructing the recombinant Saccharomyces cerevisiae strain producing nepetalactone in the present invention is as follows:
[0062] 1. Obtaining a high-yield 8-hydroxygeraniol brewer's yeast strain:
[0063] Provided by Yuan Yingjin's research group, the strain is labeled yWHR60 (strain source: Article: Systematic Engineering to Enhance 8-Hydroxygeraniol Production in Yeast).
[0064] 2. Obtaining exogenous functional gene elements and modular integration tool plasmids:
[0065] crHGO gene element: pRS424K-GAL7-crHGO-TGPD1;
[0066] nmISY gene element: pRS415K-GAL7-nmISY-TGPD1;
[0067] NEPS1 gene element: pRS426K-GAL7-NEPS1-TGPD1;
[0068] The construction process of the tool plasmid includes the following steps:
[0069] Using the crHGO gene as a template, the GAL7 promoter and TGPD1 terminator were introduced into the left and right ends of the crHGO gene by PCR to obtain the expression cassette GAL7-crHGO-TGPD1. Specifically, using the chromosome genome as a template, the GAL7 fragment and the TGPD1 fragment were obtained by PCR reaction, and then these two fragments and the crHGO gene were used as templates for OE-PCR reaction to obtain GAL7-crHGO-TGPD1. The crHGO gene element was obtained by assembling pRS424K and GAL7-crHGO-TGPD1 using seamless cloning: pRS424K-GAL7-crHGO-TGPD1.
[0070] Using the nmISY gene as a template, the GAL7 promoter and the TGPD1 terminator were introduced into the left and right ends of the nmISY gene by PCR to obtain the expression cassette GAL7-nmISY-TGPD1. Specifically, using the chromosome genome as a template, the GAL7 fragment and the TGPD1 fragment were obtained by PCR reaction, and then these two fragments and the nmISY gene were used as templates for OE-PCR reaction to obtain GAL7-nmISY-TGPD1. The nmISY gene element was obtained by assembling pRS415K and GAL7-nmISY-TGPD1 by seamless cloning: pRS415K-GAL7-nmISY-TGPD1.
[0071] Using NEPS1 gene as template, GAL7 promoter and TGPD1 terminator were introduced into the left and right ends of NEPS1 gene by PCR to obtain expression cassette GAL7-NEPS1-TGPD1. Specifically, using chromosome genome as template, GAL7 fragment and TGPD1 fragment were obtained by PCR reaction, and then these two fragments and NEPS1 gene were used as templates for OE-PCR reaction to obtain GAL7-NEPS1-TGPD1. NEPS1 gene element was obtained by assembling pRS426K and GAL7-NEPS1-TGPD1 by seamless cloning: pRS426K-GAL7-NEPS1-TGPD1.
[0072] 3. Construction of Saccharomyces cerevisiae strains producing nepetalactone by yeast transformation plasmid
[0073] The tool plasmid was transformed into the high-yield 8-hydroxygeraniol brewer's yeast yWHR60 by the lithium acetate method, and the exogenous genes crHGO, nmISY, and NEPS1 were introduced in the form of plasmids to obtain a brewer's yeast that produces nepetalactone; the transformed yeast was coated on SC-TRP-LEU-URA solid plates (synthetic yeast nitrogen source YNB 6.7g / L, glucose 20g / L, mixed amino acid powder lacking tryptophan, leucine and uracil 2g / L, 2% agar powder) for screening, and the obtained transformants were streaked for pure culture and single colonies were picked for inoculation in SC-TRP-LEU-URA liquid medium to extract yeast plasmids for PCR verification, and then sequenced and compared. The obtained yeast strains were named:
[0074] NTE01: yWHR60 with pRS424K-GAL7-crHGO-TGPD1, pRS415K-GAL7-nmISY-TGPD1, pRS426K-GAL7-NEPS1-TGPD1.
[0075] Example 2 Yield of cis-trans nepetalactone in production strains
[0076] The production of nepetalactone by strain NTE01 was detected during shake flask fermentation.
[0077] 1. Test materials: strain NTE01, cis-trans nepetalactone standard;
[0078] 2. Test methods:
[0079] Culture medium (SC-TRP-LEU-URA): synthetic yeast nitrogen source YNB 6.7 g / L, glucose 20 g / L, mixed amino acid powder lacking tryptophan, leucine and uracil 2 g / L;
[0080] The above strain glycerol was inoculated into 3 mL seed culture medium and cultured at 30 °C and 250 rpm for 16 h. 600 =0.2 was transferred to 3 mL of fresh seed culture medium and cultured at 30°C and 250 rpm for 12 h. 600 =0.2 was transferred to a 24-well deep-well plate, and the nepetalactone production was detected under the conditions of 28°C and 220rpm for 96h.
[0081] 3. Nepetalactone extraction method:
[0082] Take 1 mL of fermentation broth, centrifuge at 12000 rpm for 2 min, collect the supernatant, take 600 μL of ethyl acetate and mix with the supernatant, vortex for 10 minutes, centrifuge at 12000 rpm for 2 min, collect the upper organic phase, add excess anhydrous sodium sulfate to remove water, filter with 0.22 μm organic filter membrane, and detect by GC-MS.
[0083] 4. Nepetalactone GC-MS detection method:
[0084] The analysis of nepetalactone was carried out using a GC / MS system consisting of a Shimadzu GC-2010 PLUS gas chromatograph and a Shimadzu GCMS-QP2020 mass spectrometer. The chromatographic conditions were: constant linear velocity mode, flow rate 34.6 cm / s, split ratio 10:1. The injection port temperature was 230°C. The column temperature was first maintained at 70°C for 1 min, then increased to 150°C at 30°C / min, and then increased to 230°C at 10°C / min and maintained for 10 min. The characteristic fragment ion of cis-trans nepetalactone was 166 m / z, and the retention time was about 6.5 min.
[0085] like Figure 2 As shown, from the fermentation results, NTE01 achieved the synthesis of cis-trans nepetalactone.
[0086] Example 3 Effect of HGO and ISY fusion on the yield of nepetalactone in production strains
[0087] The strain construction method is the same as in Example 1, wherein module 1 is as follows:
[0088] pRS424K-GAL7-crHGO-nmISY-TGPD1
[0089] The resulting yeast strain was named:
[0090] NTE02: yWHR60 with pRS424K-GAL7-crHGO-nmISY-TGPD1, pRS426K-GAL7-NEPS1-TGPD1;
[0091] Deep well plate fermentation of the above strains:
[0092] The shake flask fermentation method and the extraction and detection method of nepetalactone are the same as those in Example 2.
[0093] The fermentation results are as follows Figure 3 As shown, the fusion of HGO and ISY proteins enabled the nepetalactone production strain to reach a yield of 21.81 mg / L.
[0094] Example 4 Effect of the introduction of MLPL gene on the yield of nepetalactone in the production strain
[0095] The strain construction method was the same as in Example 1, wherein module 1 was as follows: pRS425K-GAL7-MLPL-TGPD1;
[0096] The construction process of the tool plasmid includes the following steps:
[0097] Using the MLPL gene as a template, the GAL7 promoter and TGPD1 terminator were introduced into the left and right ends of the MLPL gene by PCR to obtain the expression cassette GAL7-MLPL-TGPD1. Specifically, using the chromosome genome as a template, the GAL7 fragment and the TGPD1 fragment were obtained by PCR reaction, and then these two fragments and the MLPL gene were used as templates for OE-PCR reaction to obtain GAL7-MLPL-TGPD1. The MLPL gene element was obtained by assembling pRS425K and GAL7-MLPL-TGPD1 using seamless cloning: pRS425K-GAL7-MLPL-TGPD1.
[0098] The resulting yeast strain was named:
[0099] NTE03: yWHR60 with pRS424K-GAL7-crHGO-nmISY-TGPD1, pRS426K-GAL7-NEPS1-TGPD1, pRS425K-GAL7-MLPL-TGPD1;
[0100] Deep well plate fermentation of the above strains:
[0101] The shake flask fermentation method and the extraction and detection method of nepetalactone are the same as those in Example 2.
[0102] The fermentation results are as follows Figure 4 As shown, the introduction of MLPL made the yield of nepetalactone-producing strain reach 39.82 mg / L.
[0103] Example 5 Effect of adding IPM to two-phase fermentation on the yield of nepetalactone in the production strain
[0104] The production of nepetalactone by strain NTE03 in two-phase fermentation with IPM added in shake flask was detected.
[0105] 1. Test materials: strain NTE03, cis-trans nepetalactone standard, isopropyl myristate (IPM);
[0106] 2. Test methods:
[0107] Culture medium (SC-TRP-LEU-URA): synthetic yeast nitrogen source YNB 6.7 g / L, glucose 20 g / L, mixed amino acid powder lacking tryptophan, leucine and uracil 2 g / L;
[0108] The above strain glycerol was inoculated into 3 mL seed culture medium and cultured at 30 °C and 250 rpm for 16 h. 600 =0.2 was transferred to 3 mL of fresh seed culture medium and cultured at 30°C and 250 rpm for 12 h. 600=0.2 was transferred to a 24-well deep-well plate, and 20% IPM was added after culturing at 28°C and 220 rpm for 24 h. The nepetalactone production was detected after 96 h of fermentation.
[0109] 3. Nepetalactone extraction method:
[0110] Take 1 mL of fermentation broth, centrifuge at 12000 rpm for 2 min, collect the upper organic phase, dilute 40 times with chromatographic grade n-hexane, add excess anhydrous sodium sulfate to remove water, filter with 0.22 μm organic filter membrane, and perform GC-MS detection. The detection method is the same as Example 2.
[0111] The fermentation results are as follows Figure 5 As shown, by adding the organic phase, the yield of the nepetalactone producing strain reached 207.09 mg / L.
[0112] Example 6 Effect of cofactor regulation on nepetalactone production in production strains
[0113] The method for constructing the recombinant Saccharomyces cerevisiae strain producing nepetalactone in the present invention is as follows:
[0114] 1. Obtaining recombinant Saccharomyces cerevisiae strains producing nepetalactone:
[0115] Provided by Yuan Yingjin's research group, the strain number is yWHR60.
[0116] 2. Obtaining modular integration tool plasmids:
[0117] ZWF1 gene element: provided by Yuan Yingjin's research group, TEF1p-ZWF1-TEF2t (article: Systematic Engineering to Enhance 8-Hydroxygeraniol Production in Yeast);
[0118] 3. Construction of yeast homologous recombination module
[0119] Using TEF1p-ZWF1-TEF2t as a template, the YPL062W homology arms were introduced into the left and right ends of the ZWF1 gene element by PCR to obtain the expression cassette YPL062Wup-TEF1p-ZWF1-TEF2t-YPL062Wdown. Specifically, using the chromosome genome as a template, two upstream and downstream DNA fragments of the YPL062W site were obtained by two PCR reactions, and then these two fragments and the ZWF1 gene element were used as templates for OE-PCR reactions to obtain the yeast homologous recombination module.
[0120] 4. The strain construction method is the same as in Example 1, and the obtained yeast strain is named:
[0121] NTE04:yWHR60, YPL062W::TEF1p-ZWF1-TEF2t;
[0122] The pRS424K-GAL7-crHGO-nmISY-TGPD1, pRS426K-GAL7-NEPS1-TGPD1, and pRS425K-GAL7-MLPL-TGPD1 plasmids were transformed into NTE04 using the same transformation method as in Example 1. The resulting yeast strains were named:
[0123] NTE05: NTE04, pRS424K-GAL7-crHGO-nmISY-TGPD1, pRS426K-GAL7-NEPS1-TGPD1, pRS425K-GAL7-MLPL-TGPD1
[0124] Deep well plate fermentation of the above strains:
[0125] The shake flask fermentation method and the extraction and detection method of nepetalactone are the same as those in Example 2.
[0126] The fermentation results are as follows Figure 6 As shown, by introducing zwf1 to enhance the NADPH content, the yield of nepetalactone-producing strain reached 347.37 mg / L.
[0127] Example 7 Effect of Chromosome Integration on Nepetalactone Yield in Production Strains
[0128] 1. Construction of yeast homologous recombination module
[0129] Construction of module 1: Using pRS424K-GAL7-crHGO-nmISY-TGPD1 as a template, the ADH6 homology arms were introduced into the left and right ends of the GAL7-crHGO-nmISY-TGPD1 gene element by PCR to obtain the expression cassette ADH6up-GAL7-crHGO-nmISY-TGPD1-ADH6down. Specifically, using the chromosome genome as a template, two upstream and downstream DNA fragments of the ADH6 site were obtained by two PCR reactions, and then these two fragments and the GAL7-crHGO-nmISY-TGPD1 gene element were used as templates for OE-PCR reaction to obtain the yeast homologous recombination module.
[0130] Construction of module 2: Using pRS426K-GAL7-NEPS1-TGPD1 and pRS425K-GAL7-MLPL-TGPD1 as templates, TGPD1-NEPS1-GAL1,10-MLPL-TGPD1 expression cassettes were constructed by PCR, and ARI1 homology arms were introduced into the left and right ends of the TGPD1-NEPS1-GAL1,10-MLPL-TGPD1 gene elements to obtain the expression cassette ARI1up-TGPD1-NEPS1-GAL1,10-MLPL-TGPD1-ARI1down. Specifically, using the chromosome genome as a template, two upstream and downstream DNA fragments of the ARI1 site were obtained by two PCR reactions, and then these two fragments and the TGPD1-NEPS1-GAL1,10-MLPL-TGPD1 gene elements were used as templates for OE-PCR reactions to obtain the yeast homologous recombination module.
[0131] 2. The strain construction method is the same as in Example 1, and the obtained yeast strain is named:
[0132] NTE06: yNTE04, ADH6::GAL7-crHGO-nmISY-TGPD1, ARI1::TGPD1-NEPS1-GAL1,10-MLPL-TGPD1;
[0133] Deep well plate fermentation of the above strains:
[0134] The shake flask fermentation method and the extraction and detection method of nepetalactone are the same as those in Example 2.
[0135] The fermentation results are as follows Figure 7 As shown, the yield of nepetalactone-producing strain was increased to 1056.85 mg / L through chromosomal integration.
[0136] Example 8 Effect of Completing Nutritional Deficiency Tags on Nepetalactone Yield in Production Strains
[0137] 1. Construction of yeast homologous recombination module
[0138] Construction of the module: Using pRS424K as a template, the URA3 element was obtained by PCR, and the ADH6 homology arms were introduced into the left and right ends of the URA3 gene element to obtain the expression cassette ADH6up-URA3-ADH6down. Similarly, the expression cassette OYE3up-LEU-OYE3down was constructed as follows: using the chromosome genome as a template, two upstream and downstream DNA fragments of the ADH6 and OYE3 sites were obtained by two PCR reactions, and then these two fragments and the URA3 and LEU gene elements were used as templates for OE-PCR reaction to obtain the yeast homologous recombination module.
[0139] Construction of Module 2:
[0140] The strain construction method was the same as in Example 1, and the obtained yeast strain was named:
[0141] NTE07: NTE06, ADH6::URA3, ARI1::LEU;
[0142] Deep well plate fermentation of the above strains:
[0143] The shake flask fermentation method and the extraction and detection method of nepetalactone are the same as those in Example 2.
[0144] The fermentation results are as follows Figure 8 As shown, the yield of nepetalactone-producing strain was increased to 2478.89 mg / L by supplementing the nutritional deficiency tag.
[0145] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A gene combination, characterized in that include: crHGO gene, nmISY gene and NEPS1 gene.
2. The gene combination according to claim 1, characterized in that: Also includes: MLPL gene and / or ZWF1 gene.
3. An expression cassette, characterized in that include: The gene combination according to claim 1 or 2.
4. The expression cassette according to claim 3, characterized in that include: One or more of expression cassette 1 to expression cassette 4; The expression cassette 1 comprises: the crHGO gene and / or the nmISY gene; The expression cassette 2 includes: the NEPS1 gene; The expression cassette 3 includes: the MLPL gene; The expression cassette 4 includes: the ZWF1 gene.
5. The expression cassette according to claim 3 or 4, characterized in that Also includes: One or more of a promoter, a terminator and a tag.
6. The expression cassette according to claim 5, characterized in that The promoter includes: GAL7 and / or GAL1,10; The terminator includes: GPD1 ; The tag includes: URA3 gene and / or LEU gene.
7. A recombinant strain, characterized in that Transformation, transfection and / or integration of an expression cassette according to any one of claims 3 to 6.
8. Use of the gene combination according to claim 1 or 2, the expression cassette according to any one of claims 3 to 6 and / or the recombinant strain according to claim 7 in the production and / or preparation of nepetalactone.
9. A method for preparing nepetalactone, characterized in that: The recombinant strain according to claim 7 is inoculated and fermented to obtain the nepetalactone.
10. The method according to claim 9, characterized in that The fermentation culture comprises the step of adding an organic phase; the organic phase comprises: isopropyl myristate.
